Analystreport

Aileron Therapeutics, Inc. (NASDAQ: ALRN) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $2.00 price target on the stock.

Aileron Therapeutics, Inc.  (ALRN) 
Last aileron therapeutics, inc. earnings: 11/7 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.aileronrx.com